Regeneron Pharmaceuticals REGN Unveils C5 Complement Pipeline Strategy But Execution Risks Cap NearTerm Upside ROKU Roku delivers 713 percent EPS surprise in Q1 2026 shares climb 35 percent amid upbeat investor sentiment DLO DLocal posts narrow Q4 2025 EPS beat shares gain 338 percent after earnings release CNNE Cannae posts far wider than expected Q4 2025 loss yet shares edge higher in daily trading GTE Gran shares rise 393 percent after releasing Q4 2025 results with negative earnings per share NextEra NEEN Stock Market Influencing Factors Is Estrella ESLAW stock a safe investment HIND Vyome Holdings shares fall 286 despite Q4 2025 EPS beating analyst estimates by a wide 40 margin Bristol Myers Squibb BMY Defensive Value Play Emerges Amid Low Volatility and Attractive Dividend Yield Permianville PVL Stock Worth Considering for Investors Permianville posts 013 EPS no analyst estimates